Market Closed -
Japan Exchange
02:00:00 2024-05-10 am EDT
5-day change
1st Jan Change
861
JPY
-0.23%
+2.14%
+7.62%
Sales 2022
23B
148M
Sales 2023
25.58B
164M
Capitalization
11.12B
71.38M
Net income 2022
735M
4.72M
Net income 2023
1.1B
7.07M
EV / Sales 2022
0.76
x
Net Debt
2022
6.76B
43.37M
Net Debt
2023
8.35B
53.62M
EV / Sales 2023
0.76
x P/E ratio 2022
14.8
x
P/E ratio 2023
10.1
x
Employees
878
Yield 2022
3.9%
Yield 2023
3.45%
Free-Float
63.51%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024
Apr. 15
CI
Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024
23-10-13
CI
Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for Year Ended August 2023, Payable on November 29, 2023; Provides Dividend Guidance for Year Ending August 2024
23-10-13
CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire Clarize Co., Ltd. from Toshiaki Fujita for ¥1
23-10-01
CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023
23-07-14
CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023
23-07-14
CI
Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on May 26, 2023.
23-06-27
CI
AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback announced on May 26, 2023, has closed with 100,000 shares, representing 0.71% for ¥79.57 million.
23-06-26
CI
AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.
23-05-26
CI
AFC-HD AMS Life Science Co., Ltd. authorizes a Buyback Plan.
23-05-25
CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended Feb. 2023, Payable on May 29, 2023
23-04-14
CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023
23-04-14
CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year Ending August 2023
23-04-14
CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023
23-01-13
CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023
23-01-13
CI
More news
1 day -0.23%
1 week +2.14%
Current month +1.89%
1 month -5.90%
3 months -6.72%
6 months +11.67%
Current year +7.62%
More quotes
Managers
Title Age Since
President
56
00-05-31
Chairman
55
01-03-31
Chief Administrative Officer
56
07-11-30
Members of the board
Title Age Since
Chairman
55
01-03-31
Director/Board Member
55
00-08-31
Chief Tech/Sci/R&D Officer
54
98-04-30
More insiders
Date
Price
Change
Volume
24-05-10
861
-0.23%
36,300
24-05-09
863
+0.35%
26,300
24-05-08
860
+0.35%
53,800
24-05-07
857
+1.66%
22,000
24-05-02
843
+0.48%
31,800
Delayed Quote
Japan Exchange, May 10, 2024 at 02:00 am EDT
More quotes
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
More about the company
1st Jan change
Capi.
+7.62% 77.17M +16.80% 8.43B +7.94% 7.8B +15.02% 6.82B -6.75% 3.74B -4.77% 3.77B +4.41% 1.44B +20.28% 1.04B -12.85% 890M -15.63% 812M
Special Foods & Wellbeing Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1